#Switzerland #obesity #Geneva #Lilly #WHO Foundation

WHO Foundation and Eli Lilly Join Forces to Tackle Global Obesity Crisis

In a significant development in global health, the WHO Foundation has announced a collaboration with Eli Lilly and Company aimed at strengthening health systems to effectively prevent and manage obesity. This partnership arises from the urgent need to combat one of the most pressing health challenges of our time, as global obesity rates have risen sharply in recent years.

The Unprecedented Rise in Obesity

According to the WHO, over 2.5 billion adults and more than 390 million children and adolescents worldwide were classified as overweight in 2022. Alarmingly, one in eight individuals globally lives with obesity, a figure that has more than doubled among adults since 1990. Such statistics highlight the critical need for comprehensive strategies and the importance of integrated health systems capable of addressing obesity on multiple fronts.

Commitment to Action

Eli Lilly has pledged $1.68 million to support the WHO Foundation's initiatives through 2029, demonstrating a long-term commitment to improving health systems that cater to obesity treatment and prevention. This collaboration will assist countries in identifying healthcare deficiencies and reinforcing the necessary infrastructure to combat obesity.

Anil Soni, CEO of the WHO Foundation, emphasized the importance of sustained efforts: "Addressing obesity at scale requires more than isolated programs. It requires health systems poised to respond throughout individuals' lifetimes." This partnership will focus on integrating evidence-based policies and equipping healthcare professionals with training standards essential for delivering equitable, stigma-free care across all age groups.

A Holistic Approach

The collaboration aims to facilitate early diagnosis, counseling, and treatment access while mitigating the economic burdens associated with obesity. Patrik Jonsson, Executive Vice President and President of Lilly International, expressed hope that this initiative will help slow the progression of obesity globally. He stated, "Individuals facing obesity deserve the necessary support to overcome this disease and prevent related health complications."

Addressing Health Inequities

With a growing emphasis on ensuring equitable access to healthcare, the WHO Foundation and Eli Lilly's partnership addresses the disparities present in resource-limited settings. There is a concerted effort to enhance primary healthcare services and create sustainable pathways for obesity prevention and treatment, particularly in areas where the need is most urgent.

A Global Health Perspective

The collaboration aligns with WHO's efforts to promote health equity and responds to the collaborative global call to action against obesity as a public health priority. The economic impact of overweight and obesity is projected to exceed $4 trillion by 2035, underlining the necessity of immediate and effective interventions.

As we move forward, the coordinated efforts of the WHO Foundation and Eli Lilly set a precedent for how public-private partnerships can tackle global health challenges. This bold initiative represents not just a response to the crisis of obesity but also serves as a model for future collaborations aimed at enhancing health systems worldwide to ensure that effective care is available to those who need it most.

This partnership underscores the commitment of both organizations to not only address immediate health concerns but also to forge a path toward a healthier future. As they strive towards their goals, the emphasis remains firmly on ensuring that the most vulnerable populations receive the support and care needed to improve their quality of life and health outcomes.